These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35191235)

  • 21. Update on the integrated histopathological and genetic classification of medulloblastoma - a practical diagnostic guideline.
    Pietsch T; Haberler C
    Clin Neuropathol; 2016; 35(6):344-352. PubMed ID: 27781424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Medulloblastoma].
    Yamaguchi S; Fujimura M
    No Shinkei Geka; 2023 Sep; 51(5):858-866. PubMed ID: 37743337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study.
    Delaidelli A; Dunham C; Santi M; Negri GL; Triscott J; Zheludkova O; Golanov A; Ryzhova M; Okonechnikov K; Schrimpf D; Stichel D; Ellison DW; von Deimling A; Kool M; Pfister SM; Ramaswamy V; Korshunov A; Taylor MD; Sorensen PH
    Clin Cancer Res; 2022 Jan; 28(1):116-128. PubMed ID: 34702771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid diagnosis of medulloblastoma molecular subgroups.
    Schwalbe EC; Lindsey JC; Straughton D; Hogg TL; Cole M; Megahed H; Ryan SL; Lusher ME; Taylor MD; Gilbertson RJ; Ellison DW; Bailey S; Clifford SC
    Clin Cancer Res; 2011 Apr; 17(7):1883-94. PubMed ID: 21325292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medulloblastoma: Molecular understanding, treatment evolution, and new developments.
    Liu X; Ding C; Tan W; Zhang A
    Pharmacol Ther; 2020 Jun; 210():107516. PubMed ID: 32105673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups.
    Carrie C; Kieffer V; Figarella-Branger D; Masliah-Planchon J; Bolle S; Bernier V; Laprie A; Supiot S; Leseur J; Habrand JL; Alapetite C; Kerr C; Dufour C; Claude L; Chapet S; Huchet A; Bondiau PY; Escande A; Truc G; Nguyen TD; Pasteuris C; Vigneron C; Muracciole X; Bourdeaut F; Appay R; Dubray B; Colin C; Ferlay C; Dussart S; Chabaud S; Padovani L; ;
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1204-1217. PubMed ID: 32768563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice.
    Gupta T; Shirsat N; Jalali R
    Curr Pediatr Rev; 2015; 11(2):106-19. PubMed ID: 26133181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative radiotherapy timing, molecular subgroups and treatment outcomes of Thai pediatric patients with medulloblastoma.
    Jaruthien T; Nantavithya C; Santisukwongchote S; Shuangshoti S; Techavichit P; Sosothikul D; Amornfa J; Shotelersuk K
    PLoS One; 2023; 18(1):e0271778. PubMed ID: 36649280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medulloblastoma genomics in the modern molecular era.
    Kumar R; Liu APY; Northcott PA
    Brain Pathol; 2020 May; 30(3):679-690. PubMed ID: 31799776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches.
    Menyhárt O; Győrffy B
    Cancer Metastasis Rev; 2020 Mar; 39(1):211-233. PubMed ID: 31970590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrating Molecular Subclassification of Medulloblastomas into Routine Clinical Practice: A Simplified Approach.
    Kaur K; Kakkar A; Kumar A; Mallick S; Julka PK; Gupta D; Suri A; Suri V; Sharma MC; Sarkar C
    Brain Pathol; 2016 May; 26(3):334-43. PubMed ID: 26222673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas.
    Kaur K; Kakkar A; Kumar A; Purkait S; Mallick S; Suri V; Sharma MC; Julka PK; Gupta D; Suri A; Sarkar C
    J Neurooncol; 2016 Dec; 130(3):423-430. PubMed ID: 27576698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and pre-clinical utility of genomics in medulloblastoma.
    Nör C; Ramaswamy V
    Expert Rev Neurother; 2018 Aug; 18(8):633-647. PubMed ID: 30032687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes.
    Sharma T; Schwalbe EC; Williamson D; Sill M; Hovestadt V; Mynarek M; Rutkowski S; Robinson GW; Gajjar A; Cavalli F; Ramaswamy V; Taylor MD; Lindsey JC; Hill RM; Jäger N; Korshunov A; Hicks D; Bailey S; Kool M; Chavez L; Northcott PA; Pfister SM; Clifford SC
    Acta Neuropathol; 2019 Aug; 138(2):309-326. PubMed ID: 31076851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signaling pathway deregulation and molecular alterations across pediatric medulloblastomas.
    Lhermitte B; Blandin AF; Coca A; Guerin E; Durand A; Entz-Werlé N
    Neurochirurgie; 2021 Feb; 67(1):39-45. PubMed ID: 29776650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a 23-gene expression signature for molecular subtyping of medulloblastoma in a long-term Chinese cohort.
    Wang Y; Huang J; Yin X; Xu Q; Sun Y; Yao Y; Xiong J
    Acta Neurochir (Wien); 2024 Feb; 166(1):72. PubMed ID: 38329556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timing is everything: A connection between medulloblastoma prognosis and foetal cerebellar development.
    Williamson D; Schwalbe EC; Bailey S; Clifford SC
    Neuropathol Appl Neurobiol; 2023 Jun; 49(3):e12903. PubMed ID: 37021628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
    Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
    PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medulloblastoma in Adults: Cytogenetic Phenotypes Identify Prognostic Subgroups.
    Goschzik T; Zur Muehlen A; Doerner E; Waha A; Friedrich C; Hau P; Pietsch T
    J Neuropathol Exp Neurol; 2021 Apr; 80(5):419-430. PubMed ID: 33870422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic Accuracy of a Reduced Immunohistochemical Panel in Medulloblastoma Molecular Subtyping, Correlated to DNA-methylation Analysis.
    Tauziède-Espariat A; Huybrechts S; Indersie E; Dufour C; Puget S; Chivet A; Roux A; Pagès M; Gareton A; Chrétien F; Lechapt E; Ayrault O; Varlet P
    Am J Surg Pathol; 2021 Apr; 45(4):558-566. PubMed ID: 33323893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.